Mechanisms responsible for mineralocorticoid receptor-dependent renal injury
Mechanisms responsible for mineralocorticoid receptor-dependent renal injury
批准号:
20590253
负责人:
NISHIYAMA Akira
金额:
$3.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010
中文摘要
已有研究表明,醛固酮和盐皮质激素受体(MR)在肾脏损伤的病理生理学中可能起作用。我们已经证明MR拮抗剂对2型糖尿病大鼠具有血压非依赖性的肾脏保护作用。我们还发现,MR不仅在肾远端小管细胞中表达,而且在其他肾上皮细胞和非上皮细胞中也有表达,包括近端肾小管细胞、肾小球系膜细胞、足细胞和肾间质成纤维细胞。醛固酮通过激活MAP激酶和产生活性氧来诱导细胞损伤。用MR拮抗剂治疗可抑制由醛固酮引起的肾细胞损伤。糖皮质激素和高糖也可通过MR激活诱导类似的细胞损伤。这些观察表明,局部表达的MR通过多种途径参与了肾脏损伤,而这些途径不能简单地用高水平的醛固酮来解释。
英文摘要
Possible roles of aldosterone and mineralocorticoid receptor (MR) in the pathphysiology of renal injury have been indicated. We have demonstrated that MR antagonist elicits blood-pressure independent renoprotective effect in type 2 diabetic rats. We also showed that MR is expressed not only in renal distal tubular cells, but also in other renal epithelial and non-epithelial cells including proximal tubular cells, glomerular mesangial cells, podocytes and renal interstitial fibroblasts. Aldosterone induced cell injury through the activation of MAP kinases and reactive oxygen species generation. Treatment with an MR antagonist inhibits renal cell injuries induced by aldosterone. Similar cell injuries were also induced through MR activation by glucocorticoid and high glucose. These observations suggest that locally expressed MR is involved in renal injury through multiple pathways that cannot be simply explained by high aldosterone levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
アルドステロンブレイクスルー
醛固酮突破
DOI:
--
发表时间:
2010
期刊:
腎と透析 Vol.68
影响因子:
--
作者:
[北田研人, 中野大介, 西山成]
通讯作者:
西山成
アンジオテンシンIIはNa+/H+ exchanger-1と酸化ストレスを介してポドサイトのアポトーシスを生じる
血管紧张素 II 通过 Na+/H+ 交换器-1 和氧化应激引起足细胞凋亡
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Liu Y]
通讯作者:
Liu Y
Olmesartan ameliorates the impairment of renal function in aortic regurgitation model Rats
奥美沙坦改善主动脉瓣反流模型大鼠肾功能损伤
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[大西啓右, 他, 西山成, 藤田昌子, 柴山弓季, Liu Y, Shamshad S, Kazi R]
通讯作者:
Kazi R
Effects of prorenin of vascular smooth muscle cell proliferation and hypertrophy via EGF receptor-mediated ERK and AKT activation pathway
肾素原通过EGF受体介导的ERK和AKT激活途径对血管平滑肌细胞增殖和肥大的影响
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Takeuchi, et al, 人見浩史]
通讯作者:
人見浩史
High sodium augments angiotensin II-induced proliferation of rat vascular smooth muscle cell through ERK1/2 dependent pathway
高钠通过 ERK1/2 依赖性途径增强血管紧张素 II 诱导的大鼠血管平滑肌细胞增殖
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Sherajee S, et al., 西山成, Konishi Y, Sofue T, Yamamoto T, 人見浩史, 人見浩史, 人見浩史]
通讯作者:
人見浩史
共 169 条
Development of locus-specific single cell analysis of chromatin modifications in tissue
-
批准号:19K07372
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2019
-
负责人:NISHIYAMA Akira
-
依托单位:
Roles of the histone variant H3.3 on the distal enhancer of differentiation specific gene.
-
批准号:26460373
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2014
-
负责人:NISHIYAMA Akira
-
依托单位:
Shared mechanisms of the transcription factor IRF8 and the cAMP pathway in macrophage differentiation
-
批准号:23590343
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:NISHIYAMA Akira
-
依托单位:
Investigation of effects of VDT work on the onset, duration, and deterioration of TMD
-
批准号:23592837
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2011
-
负责人:NISHIYAMA Akira
-
依托单位:
Possible mechanisms responsible for mineralocorticoid-induced renal injury
-
批准号:23590303
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:NISHIYAMA Akira
-
依托单位:
Causality and channels on economic growth, inequality and poverty
-
批准号:19730208
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.05万
-
财政年份:2007
-
负责人:NISHIYAMA Akira
-
依托单位:
海外基金